ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994